Comparison of Two Budesonide Dry Powder Inhalers in the Treatment of Asthma in Children

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 1, 2004, Pages 15-24

  Vanto, T ^a   Hamalainen K M ^b   Vahteristo, Mikko ^b   Wille, S ^c   Nja F ^d   Hyldebrandt, N ^d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b ORION CORPORATION   (Finland)

^c HELSINGBORG HOSPITAL   (Sweden)

^d Orion Corporation Orion Pharma ^*  (Denmark)

Author keywords

Asthma; Budesonide; Children; Easyhaler ; Efficacy; Safety; Turbuhaler

Indexed keywords

BUDESONIDE; GIONA;

ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRY POWDER; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; INTERMETHOD COMPARISON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PALLIATIVE THERAPY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS;

EID: 1942468928     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/089426804322994424     Document Type: Article

References (27)

1. Haahtela, T., Vidgren, M., Nyberg, A., et al. 1994. A novel multidose powder inhaler. Salbutamol powder and aerosol give equal bonchodilatation with equal doses. Ann. Allergy 72:178-182.
2. Chapman, K.R., Friberg, M.S., Balter, M.S., et al. 1997. Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma. Ann. Allergy Asthma Immunol. 78:59-63.
3. Koskela, T., Hedman, J., Ekroos, H., et al. 2000. Equivalence of two steroid-containing inhalers: Easyhaler multidose powder inhaler compared with conventional aerosol with large volume spacer. Respiration 67:194-202.
4. Nieminen, M.M., Vidgren, P., Kokkarinen, J., et al. 1998. A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma. Respiration 65:275-281.
5. Thorsson, L., Edsbäcker, S., and Conradson, T.-B. 1994. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler (p-MDI). Eur. Respir. J. 7:1839-1844.
6. Pedersen, S. 1994. Inspiratory capacity through the Turbuhaler® in various patient groups. J. Aerosol Med. 7:S55-S58.
7. Bisgaard, H., Pedersen, S., and Nikander, K. 1994. Use of budesonide Turbuhaler® in young children suspected of asthma. Eur. Respir. J. 7:740-742.
8. Ahlström, H., Svevonius, E., and Svensson, M. 1989. Treatment of asthma in preschool children with inhalation of terbutaline in Turbuhaler® compared with Nebuhaler®. Allergy 44:525-528.
9. Goren, A., Novinski, N., Avital, A., et al. 1994. Assessment of the ability of young children to use powder inhaler device (Turbuhaler®). Pediatr. Pulmonol. 18:77-80.
10. Global Initiative for Asthma. 2002. Global Strategy for Asthma Management and Prevention. NHLB/WHO Workshop Report. Publication no. 02-3659. National Institutes of Health, National Heart, Lung and Blood Institute.
11. Polgar, G., and Promadhat, V. 1971. Pulmonary Function Testing in Children: Techniques and Standards. WB Saunders, London.
12. The British guidelines on asthma management 1997: 1995 review and position statement. Thorax 52(Suppl 1):S1-S21.
13. Busse, W.W., Chervinsky, P., Condemi, J., et al. 1998. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J. Allergy Clin. Immunol. 101:457-463.
14. Pritchard, J.N. 2001. The influence of lung deposition on clinical response. J. Aerosol Med. 14(Suppl 1): S19-S26.
15. Pedersen, S., and O'Byrne, P. 1997. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 52(Suppl 39):1-34.
16. Clark, D.J., Clark, R.A., and Lipworth, B.J. 1996. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax 51:941-943.
17. Wolthers, O.D., Hansen, M., Juul, A., et al. 1997. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids. Pediatr. Res. 41:44-50.
18. Lipworth, B.J., Clark, D.J., and McFarlane, L.C. 1997. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Thorax 52:686-689.
19. Hirst, P.H., Bacon, R.E., Pitcairn, G.R., et al. 2001. A comparison of the lung deposition of budesonide from Easyhaler®, Turbuhaler®, and pMDI plus spacer in asthmatic patients. Respir. Med. 95:720-727.
20. Clark, D.J., Clark, R.A., and Lipworth, B.J. 1996. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax 51:941-943.
21. Wolthers, O.D. 1996. Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids. Eur. Respir. J. 9: 821-827.
22. Brand, P.L.P. 2001. Inhaled corticosteroids reduce growth. Or do they? Eur. Respir. J. 17:287-294.
23. Wolthers, O.D., and Pedersen, S. 1991. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 303:163-165.
24. Agertoft, L., and Pedersen, S. 2000. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N. Engl. J. Med. 343:1064-1069.
25. Kamps, A.W., Roorda, R.J., and Brand, P.L. 2001. Peak flow diaries in childhood asthma are unreliable. Thorax 56:180-182.
26. Pelkonen, A.S., Nikander, K., and Turpeinen, M. 2000. Reproducibility of home spirometry in children with newly diagnosed asthma. Pediatr. Pulmonol. 29:34-38.
27. Jonasson, G., Carlsen, K.H., and Mowinckel, P. 2000. Asthma drug adherence in a long-term clinical trial. Arch. Dis. Child. 83:330-333.